Hey buddy, good to see you posting again, I agree but still do not see any value in GTXI anymore and would not buy it even at 2.00. VKTX pipeline has so much more potential and so many near term catalysts in Q4. Still glad your riding this stock up. I still am holding all my shares from 1.40 and not planning on selling till the valuation is equally valued to MDGL which would be 50.00.
Waffles , Any thoughts on this article that suggests the NAFL results were good but for NASH they would have to do a Phase 2b trial for Biopsy's . Or can they include it in Phase 3 ??? Also would like your opinion on the writers suggestion combine of VK2809 and 0612 ?
" I recommend to Dr. Lian that inhibiting/suppressing lipogenesis, glucose production and its metabolism in the liver with VK0612/VK2809 combo, should limit both insulin resistance, ensuing steatosis and inflammation-mediated hepatic fibrosis."
News 
Market Data 
Discover 
